News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,168 Results
Type
Article (87450)
Company Profile (760)
Press Release (772934)
Multimedia
Podcasts (174)
Webinars (28)
Section
Business (233061)
Career Advice (4140)
Deals (39796)
Drug Delivery (137)
Drug Development (91255)
Employer Resources (203)
FDA (18285)
Job Trends (17400)
News (397409)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (125)
Alliances (56980)
ALS (146)
Alzheimer's disease (1681)
Antibody-drug conjugate (ADC) (248)
Approvals (18312)
Artificial intelligence (496)
Autoimmune disease (77)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (161)
Biotechnology (484)
Bladder cancer (134)
Brain cancer (53)
Breast cancer (512)
Cancer (3992)
Cardiovascular disease (339)
Career advice (3559)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (687)
Cervical cancer (33)
Clinical research (75567)
Collaboration (1397)
Company closure (4)
Compensation (940)
Complete response letters (59)
COVID-19 (2959)
CRISPR (81)
C-suite (597)
Cystic fibrosis (136)
Data (4539)
Decentralized trials (2)
Denatured (62)
Depression (112)
Diabetes (455)
Diagnostics (7094)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (236)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98832)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133045)
Executive appointments (992)
FDA (20771)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1261)
Gene editing (173)
Generative AI (50)
Gene therapy (548)
GLP-1 (1022)
Government (5386)
Grass and pollen (7)
Guidances (344)
Healthcare (20937)
HIV (48)
Huntington's disease (38)
IgA nephropathy (63)
Immunology and inflammation (242)
Immuno-oncology (21)
Indications (53)
Infectious disease (3205)
Inflammatory bowel disease (188)
Inflation Reduction Act (15)
Influenza (101)
Intellectual property (192)
Interviews (815)
IPO (17927)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (16)
Labor market (78)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (12)
Lung cancer (577)
Lymphoma (267)
Machine learning (31)
Management (66)
Manufacturing (643)
MASH (140)
Medical device (14872)
Medtech (14897)
Mergers & acquisitions (22751)
Metabolic disorders (1161)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (230)
Neuropsychiatric disorders (62)
Neuroscience (2722)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (560)
Opinion (314)
Ovarian cancer (135)
Pain (166)
Pancreatic cancer (172)
Parkinson's disease (242)
Partnered (30)
Patents (423)
Patient recruitment (315)
Peanut (57)
People (66273)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23310)
Phase II (32801)
Phase III (24713)
Pipeline (2739)
Policy (295)
Postmarket research (3554)
Preclinical (10506)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (679)
Real estate (7422)
Recruiting (79)
Regulatory (28035)
Reports (65)
Research institute (2691)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (73)
Schizophrenia (136)
Series A (210)
Series B (157)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1052)
Venture capital (67)
Weight loss (397)
Women's health (59)
Worklife (21)
Date
Today (151)
Last 7 days (743)
Last 30 days (2675)
Last 365 days (33649)
2025 (26704)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (303)
Arkansas (14)
Asia (50991)
Australia (8961)
California (9496)
Canada (2874)
China (909)
Colorado (404)
Connecticut (425)
Delaware (271)
Europe (117150)
Florida (1398)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (813)
India (51)
Indiana (463)
Iowa (20)
Japan (327)
Kansas (124)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1280)
Massachusetts (7143)
Michigan (315)
Minnesota (564)
Mississippi (4)
Missouri (121)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2643)
New Mexico (32)
New York (2587)
North Carolina (1416)
North Dakota (10)
Northern California (4305)
Ohio (299)
Oklahoma (22)
Oregon (50)
Pennsylvania (1977)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3625)
Tennessee (150)
Texas (1491)
United States (35120)
Utah (283)
Virginia (250)
Washington D.C. (83)
Washington State (822)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 861,168 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody
The deal focuses on ICT01, a monoclonal antibody being tested in acute myeloid leukemia. ImCheck is also developing assets in infectious disease and other oncology indications.
October 22, 2025
·
1 min read
·
Dan Samorodnitsky
Layoff Tracker
Galapagos Plans Cell Therapy Exit, Potentially Affecting 365 Employees
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
October 22, 2025
·
73 min read
·
BioSpace Editorial Staff
Drug pricing
Trump To Target Trading Partners With Drug Pricing Probe: Report
While the threat of tariffs dies down for the pharma industry, President Donald Trump is reportedly weighing a new investigation that could result in import taxes against U.S. trading partners that don’t pay enough for drugs.
October 22, 2025
·
1 min read
·
Annalee Armstrong
Job Trends
Most Employers Consider Hiring But Worry About Overqualified Job Candidates: Survey
Seven in 10 U.S. hiring managers say their company usually considers employing overqualified applicants, according to a survey from Express Employment Professionals and The Harris Poll. However, 75% of employers believe such hires struggle to stay motivated in lower-level roles.
October 22, 2025
·
3 min read
·
Angela Gabriel
Press Releases
OS Therapies Announces Overall and Event Free Survival Key Subgroup Data for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
October 22, 2025
·
5 min read
Press Releases
Transcenta Announces the Appointment of Tyler Marciniak as Senior Vice President of Capital Markets, Investor Relations and Corporate Communications
October 22, 2025
·
1 min read
Press Releases
Finetech Unveils Eco-Friendly Packaging Line Compatible With Compostable and Recyclable Materials
October 22, 2025
·
4 min read
Press Releases
Stem Cell Banking Market to Worth USD 35.12 Billion, Forecasts 16.14% CAGR by 2034
October 22, 2025
·
1 min read
Press Releases
TSRL Awarded $2.2 Million Phase II SBIR Grant from the National Institutes of Health (NIH) to Advance Microneedle Patch for Overactive Bladder Therapy
October 22, 2025
·
1 min read
Events
Cracking the Code: Phil Sharp and the Biotech Revolution
Please join us at the Johns Hopkins University Bloomberg Center for a groundbreaking look at Phil Sharp’s rise from a rural Kentucky farm boy who battled dyslexia to Nobel Prize-winning scientist
October 22, 2025
1 of 86,117
Next
